Pharma, Biotech Patenting Down, Lawsuits Up, Survey Finds
Patent litigation has continued at a modest, steady increase, a likely reflection of the continued recognition of the increased value of intellectual property assets. Biotech and pharmaceutical patent litigation appear consistent with this trend, according to the report.
The study found that the number of biotech and pharmaceutical cases at U.S. district courts and...
To view the full article, register now.